Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Appointed director
CC transcript
BRISTOL MYERS SQUIBB CO (BMY) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/26/2018 BW Bristol-Myers Squibb Reports First Quarter Financial Results
03/14/2018 BW Bristol-Myers Squibb to Announce Results for First Quarter 2018 on April 26
02/05/2018 BW Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results
01/03/2018 BW Bristol-Myers Squibb to Present at J.P. Morgan Healthcare Conference
12/19/2017 BW Bristol-Myers Squibb to Announce Results for Fourth Quarter 2017 on February 5th
11/30/2017 BW Bristol-Myers Squibb to Take Part at the Citi 2017 Global Healthcare Conference
10/26/2017 BW Bristol-Myers Squibb Reports Third Quarter Financial Results
09/07/2017 BW Bristol-Myers Squibb to Announce Results for Third Quarter 2017 on October 26
07/27/2017 BW Bristol-Myers Squibb Reports Second Quarter Financial Results
06/12/2017 BW Bristol-Myers Squibb to Announce Results for Second Quarter 2017 on July 27
06/07/2017 BW Bristol-Myers Squibb to Take Part in Goldman Sachs 38th Annual Global Healthcare Conference
05/26/2017 BW CORRECTING and REPLACING Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights
05/26/2017 BW Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights
04/27/2017 BW Bristol-Myers Squibb Reports First Quarter Financial Results
03/10/2017 BW Bristol-Myers Squibb to Announce Results for First Quarter 2017 on April 27
03/08/2017 BW Bristol-Myers Squibb to Take Part in Barclays Global Health Care Conference
02/27/2017 BW Bristol-Myers Squibb to Take Part in Cowen and Company 37th Annual Global Health Care Conference
02/08/2017 BW Bristol-Myers Squibb to Take Part in Leerink 6th Annual Global Health Care Conference
08/15/2011 BW Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ESC Highlights
08/15/2011 BW Bristol-Myers Squibb Announces the Winners of the 2011 REYATAZ® (atazanavir sulfate) “Fight HIV Your Way” Contest
07/21/2011 BW Bristol-Myers Squibb to Acquire Amira Pharmaceuticals
07/20/2011 BW Data on Bristol-Myers Squibb's Investigational Treatment for Alzheimer's Disease Demonstrate Potential Therapeutic Window at Doses Below 100 mg in Phase II Safety and Tolerability Study
07/19/2011 BW FDA Advisory Committee Makes Recommendation on Investigational Compound Dapagliflozin
07/06/2011 BW Bristol-Myers Squibb and Innate Pharma Announce Breakthrough Global License Agreement for an Investigational Immuno-Oncology Biologic
07/05/2011 BW Innovative Curriculum Helps Teachers Meet NJ Standards for 21st Century Essential Work Force Skills
06/26/2011 BW Investigational Compound Dapagliflozin Added to Metformin Sustained Reductions in Blood Sugar Levels in Adult Patients with Type 2 Diabetes in Two-Year Study
06/25/2011 BW Investigational Compound Dapagliflozin Sustained Glycemic Control and Weight Reduction in Study of Type 2 Diabetes Patients Inadequately Controlled with Metformin
06/25/2011 BW Investigational Study Reported ONGLYZA™ (saxagliptin) Added to Insulin Significantly Improved Blood Sugar Levels in Adults with Type 2 Diabetes Compared to Placebo Added to Insulin
06/24/2011 BW Bristol-Myers Squibb Foundation Awards $1.5 Million in Grants to Help African American Women Fight Type 2 Diabetes
06/05/2011 BW Second Phase 3 Study of YERVOY™ (ipilimumab) in Metastatic Melanoma Meets Primary Endpoint of Overall Survival
06/01/2011 BW Bristol-Myers Squibb to Take Part in Goldman Sachs Health Care Conference June 8
05/23/2011 BW Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights
04/29/2011 BW Bristol-Myers Squibb Invites Public to Listen to Webcast of 2011 Annual Meeting
04/28/2011 BW CORRECTING and REPLACING Bristol-Myers Squibb Delivers Excellent First Quarter with YERVOY™ (ipilimumab) Approval, Key R&D Milestones and Strong Financials
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy